1402054-40-3

Upstream product

• 1361198-34-6 ethyl 2-(4-(4-acetylpiperazin-1-yl)phenoxy)acetate 
• 1402054-36-7 tert-butyl 4-(4-(2-ethoxy-2-oxoethoxy)phenyl)piperazine-1-carboxylate 
• 929884-17-3 4-chloro-1-(2-chloroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-amine 
• 4344-84-7 5-oxo-tetrahydro-furan-2-carboxylic acid 
• 100644-65-3 4-chloro-1H-pyrazolo[3,4-d]pyrimidine-6-amine 
• 5604-46-6 2-amino-4,6-dichloropyrimidine-5-carboxaldehyde 
• 82977-45-5 tetrahydro-5-oxofuran-2-carboxylic acid chloride 
• 67914-60-7 N-acetyl-N'-(4-hydroxyphenyl)piperazine 
• 158985-25-2 tert-butyl 4-(4-hydroxyphenyl)piperazine-1-carboxylate 

Downstream Products

• 1402054-41-4 ethyl 2-(4-(4-(2-(5-amino-2-(5-oxotetrahydrofuran-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-7-yl)ethyl)piperazin-1-yl)phenoxy)acetate 

Relevant academic research and scientific papers

METABOLITES OF 2-(FURAN-2-YL)-7-(2-(4-(4-(2-METHOXYETHOXY)PHENYL)PIPERAZIN-1-YL)ETHYL)-7H-PYRAZOLO[4,3-e][1,2,4]TRIAZOLO[1,5-c]PYRIMIDIN-5-AMINE AND THEIR UTILITY AS ADENOSINE A2a RECEPTOR ANTAGONISTS

The present invention provides a compound of the (formula:(I) or a pharmaceutically acceptable salt thereof in isolated and purified form. The compound is an adenosine A2a receptor antagonists useful in treatment of central nervous system disorders, such